A veia renal esquerda (VRE) se localiza anteriormente à artéria aorta abdominal e posteriormente mesentérica. Essa posição favorece a compressão da VRE, fato que tem como consequência manifestação síndrome do quebra nozes (SQN). Contudo, presença de uma variação anatômica extremamente rara na qual VRE assume retroaórtica apresenta um possível fator preventivo SQN. Assim, esta revisão literatura...

Introduction Since first isolated in 1986 in Europe (1) vancomycin-resistant enterococcus (VRE) have emerged as a major nosocomial pathogen. Since then, VRE have been reported at an increasing number in countries outside Europe and the USA, such as in Singapore (2), Japan (3), Australia (4), and Korea (5). VRE is also a concern in Malaysia, however cases of VRE in human hospitals are uncommon (...

Ramoplanin is a glycolipodepsipeptide antibiotic with activity against gram-positive bacteria that is in clinical trials for prevention of vancomycin-resistant Enterococcus (VRE) bloodstream infections and treatment of Clostridium difficile diarrhea. Orally administered ramoplanin suppresses VRE intestinal colonization, but recurrences after discontinuation of treatment have frequently been obs...

BACKGROUND Vancomycin-resistant entrococci (VRE) are increasing in prevalence at many institutions, and are often reported in dialysis patients. The aim of this cross-sectional prevalence study was to determine the prevalence and risk factors of VRE colonization in chronic hemodialysis patients in two hemodialysis centers in Shiraz, Iran. METHODS Rectal swabs were obtained from all consenting...

BACKGROUND Vancomycin-resistant enterococci (VRE) have emerged as a growing problem in hospitals; however, domesticated animals, poultry, and wild birds are acting as potential reservoirs. There is a knowledge gap in the Epidemiology of VRE from Bangladesh. METHODS To study the prevalence of VRE and the mechanisms of resistance implicated among wild birds, 238 fecal samples were collected in ...

Nosocomial vancomycin-resistant Enterococcus (VRE) infections have been described in only small numbers of pediatric patients. In none of these studies were multivariate analyses performed to assess which factors were independent risk factors in these patients. In the present cohort study of patients admitted to our hematology/oncology unit, surveillance cultures revealed a colonization rate of...

The first cases with vancomycin-resistant Enterococci (VRE) isolation were reported in 1988 throughout the world, and in 1998 in Turkey. The number of the papers conducted on cases or epidemics in which VRE was isolated is in increase. In this study, it was aimed to evaluate some studies at this topic. In conclusion, it was observed that the VRE strains isolated in the same clinic within a shor...

Although nosocomial acquisition and subsequent colonization of vancomycin-resistant enterococci (VRE), an emerging international threat to public health, has been emphasized in the United States, colonization among nonhospitalized persons has been infrequently documented. In contrast, in Europe, colonization appears to occur frequently in persons outside the health-care setting. An important fa...

INTRODUCTION Vancomycin-resistant enterococcus (VRE) can cause serious infections in vulnerable, immunocompromised patients. MATERIALS AND METHODS In this article, we summarise current data on epidemiology, detection, treatment and prevention of VRE. RESULTS VRE was first isolated in Singapore in 1994 and until 2004 was only sporadically encountered in our public hospitals. After 2 outbreak...

An in vitro anaerobic continuous-flow competitive exclusion (CFCE) culture model was used to study the ability of human stool flora to inhibit the growth of vancomycin-resistant (VR) enterococci (VRE). The CFCE culture was established from a stool sample obtained from a healthy adult. When 10(3) or 10(6) cfu/mL of VR Enterococcus faecium were added to the CFCE culture, the VRE were eliminated w...